- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07786818
Metatranscriptomic Markers of Colonic Neoplasia
August 24, 2026 updated by: Viome
Metatranscriptomic Markers As A Predictor of Colonic Neoplasia at the Time of Colonoscopy
This study is a collaboration between Viome Life Sciences and Scripps Research Institute to develop and validate a noninvasive molecular diagnostic test for the detection of colorectal polyps.
Approximately 1,000 participants undergoing colonoscopy will provide saliva and stool samples prior to their procedure.
Molecular features identified in these samples will be evaluated in relation to colonoscopy findings to develop a predictive model for colorectal polyp detection.
The resulting model will then be evaluated in an independent validation dataset to assess its performance for identifying individuals with colorectal polyps.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Momchilo Vuyisich, PhD
- Phone Number: 855-958-4663
- Email: studies@viome.com
Study Locations
-
-
Washington
-
Bothell, Washington, United States, 98011
- Recruiting
- Viome Life Sciences
-
Contact:
- Momchilo Vuyisich, PhD
- Phone Number: 855-958-4663
- Email: studies@viome.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
- Male or female, aged 18 years or older
- Undergoing colonoscopy with bowel preparation
- Able to provide stool and saliva samples prior to colonoscopy
- No stoma present
- No known personal history of colorectal cancer
Description
Inclusion Criteria:
- Male or female, aged 18 years or older
- Undergoing colonoscopy with bowel preparation
- Able to provide stool and saliva samples prior to colonoscopy
- No stoma present
- No known personal history of colorectal cancer
Exclusion Criteria:
- Individuals under 18 years of age
- Patients with a stoma
- Personal history of colorectal cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic performance
Time Frame: Participants collect study samples between 4 weeks and 1 day prior to initiation of bowel preparation for colonoscopy. Colonoscopy findings and associated pathology results are subsequently collected electronically as part of the study.
|
Performance of the molecular classifier for identifying participants with one or more colorectal polyps, using colonoscopy and pathology findings as the reference standard.
Performance will be assessed in an independent validation dataset using sensitivity, specificity, area under the receiver operating characteristic curve, positive predictive value, and negative predictive value.
|
Participants collect study samples between 4 weeks and 1 day prior to initiation of bowel preparation for colonoscopy. Colonoscopy findings and associated pathology results are subsequently collected electronically as part of the study.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 20, 2025
Primary Completion (Estimated)
January 30, 2027
Study Completion (Estimated)
January 30, 2027
Study Registration Dates
First Submitted
August 10, 2026
First Submitted That Met QC Criteria
August 24, 2026
First Posted (Actual)
August 26, 2026
Study Record Updates
Last Update Posted (Actual)
August 26, 2026
Last Update Submitted That Met QC Criteria
August 24, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- V314
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.